Clinical Trial Update: Perennial Allergic Rhinitis Study In Pediatric Subjects [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial for perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED